AAAAAA

   
Results: 1-15 |
Results: 15
Correction of positive bias of the Roche Tina-quant II hemoglobin A1c (HbA1c) assay at low HbA1c percentages
Authors: Nowatzke, WL Parvin, CA Scott, MG Hock, K Cole, TG
Citation: Wl. Nowatzke et al., Correction of positive bias of the Roche Tina-quant II hemoglobin A1c (HbA1c) assay at low HbA1c percentages, CLIN CHEM, 47(5), 2001, pp. 976-978
Optimization of beta-quantification methods for high-throughput applications
Authors: Cole, TG Ferguson, CA Gibson, DW Nowatzke, WL
Citation: Tg. Cole et al., Optimization of beta-quantification methods for high-throughput applications, CLIN CHEM, 47(4), 2001, pp. 712-721
Standardization of lipoprotein reporting
Authors: Kroll, MH Cole, TG Rifai, N Cooper, G Warnick, GR Jialal, I
Citation: Mh. Kroll et al., Standardization of lipoprotein reporting, AM J CLIN P, 114(5), 2000, pp. 696-702
Differences in the A beta 40/A beta 42 ratio associated with cerebrospinalfluid lipoproteins as a function of apolipoprotein E genotype
Authors: Fagan, AM Younkin, LH Morris, JC Fryer, JD Cole, TG Younkin, SG Holtzman, DM
Citation: Am. Fagan et al., Differences in the A beta 40/A beta 42 ratio associated with cerebrospinalfluid lipoproteins as a function of apolipoprotein E genotype, ANN NEUROL, 48(2), 2000, pp. 201-210
Analytical and clinical performance of a detergent-based homogeneous LDL-cholesterol assay: A multicenter evaluation
Authors: Nauck, M Graziani, MS Bruton, D Cobbaert, C Cole, TG Lefevre, F Riesen, W Bachorik, PS Rifai, N
Citation: M. Nauck et al., Analytical and clinical performance of a detergent-based homogeneous LDL-cholesterol assay: A multicenter evaluation, CLIN CHEM, 46(4), 2000, pp. 506-514
VLDL, apolipoproteins B, CIII, and E, and risk of recurrent coronary events in the Cholesterol and Recurrent Events (CARE) trial
Authors: Sacks, FM Alaupovic, P Moye, LA Cole, TG Sussex, B Stampfer, MJ Pfeffer, MA Braunwald, E
Citation: Fm. Sacks et al., VLDL, apolipoproteins B, CIII, and E, and risk of recurrent coronary events in the Cholesterol and Recurrent Events (CARE) trial, CIRCULATION, 102(16), 2000, pp. 1886-1892
Cholesterol and recurrent events trial (CARE) - The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels
Authors: Sacks, FM Pfeffer, MA Moye, LA Hawkins, CM Davis, BR Rouleau, JL Cole, TG Braunwald, E
Citation: Fm. Sacks et al., Cholesterol and recurrent events trial (CARE) - The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels, CHOLESTEROL-LOWERING THERAPY, 2000, pp. 63-89
A new liquid homogeneous assay for HDL cholesterol determination evaluatedin seven laboratories in Europe and the United States
Authors: Nauck, M Graziani, MS Jarausch, J Bruton, D Cobbaert, C Cole, TG Colella, F Lefevre, F Gillery, P Haas, B Law, T Konig, M Macke, M Marz, W Meier, C Riesen, W van Vliet, M Wieland, H Rifai, N
Citation: M. Nauck et al., A new liquid homogeneous assay for HDL cholesterol determination evaluatedin seven laboratories in Europe and the United States, CLIN CH L M, 37(11-12), 1999, pp. 1067-1076
Structure of mangrove trees and forests in Micronesia
Authors: Cole, TG Ewel, KC Devoe, NN
Citation: Tg. Cole et al., Structure of mangrove trees and forests in Micronesia, FOREST ECOL, 117(1-3), 1999, pp. 95-109
Known mutations of apoB account for only a small minority of hypobetalipoproteinemia
Authors: Wu, JS Kim, J Li, Q Kwok, PY Cole, TG Cefalu, B Averna, M Schonfeld, G
Citation: Js. Wu et al., Known mutations of apoB account for only a small minority of hypobetalipoproteinemia, J LIPID RES, 40(5), 1999, pp. 955-959
High-throughput measurement of oxidizability of low-density lipoproteins suitable for use in clinical trials
Authors: Cole, TG Parikh, N
Citation: Tg. Cole et N. Parikh, High-throughput measurement of oxidizability of low-density lipoproteins suitable for use in clinical trials, CLIN CHEM, 45(5), 1999, pp. 696-699
Selection, validation, standardization, and performance of a designated comparison method for HDL-cholesterol for use in the cholesterol reference method laboratory network
Authors: Kimberly, MM Leary, ET Cole, TG Waymack, PP
Citation: Mm. Kimberly et al., Selection, validation, standardization, and performance of a designated comparison method for HDL-cholesterol for use in the cholesterol reference method laboratory network, CLIN CHEM, 45(10), 1999, pp. 1803-1812
Reflex testing - I: Algorithm for lipid and lipoprotein measurement in coronary heart disease risk assessment
Authors: Wu, AHB Contois, JH Cole, TG
Citation: Ahb. Wu et al., Reflex testing - I: Algorithm for lipid and lipoprotein measurement in coronary heart disease risk assessment, CLIN CHIM A, 280(1-2), 1999, pp. 181-193
Baseline cholesterol level and magnitude of coronary event reduction in diabetic patients with myocardial infarction - Response
Authors: Sacks, FM Pfeffer, MA Braunwald, E Goldberg, RB Mellies, MJ Moye, LA Davis, BR Howard, BV Howard, WJ Cole, TG
Citation: Fm. Sacks et al., Baseline cholesterol level and magnitude of coronary event reduction in diabetic patients with myocardial infarction - Response, CIRCULATION, 100(25), 1999, pp. E154-E154
Cardiovascular events and their reduction with pravastatin in diabetic andglucose-intolerant myocardial infarction survivors with average cholesterol levels - Subgroup analyses in the cholesterol and recurrent events (CARE)trial
Authors: Goldberg, RB Mellies, MJ Sacks, FM Moye, LA Howard, BV Howard, WJ Davis, BR Cole, TG Pfeffer, MA Braunwald, E
Citation: Rb. Goldberg et al., Cardiovascular events and their reduction with pravastatin in diabetic andglucose-intolerant myocardial infarction survivors with average cholesterol levels - Subgroup analyses in the cholesterol and recurrent events (CARE)trial, CIRCULATION, 98(23), 1998, pp. 2513-2519
Risultati: 1-15 |